Doing Business with Us
As we work towards our ambitious but achievable goal of ending the HIV epidemic by 2030, the Centers for Disease Control and Prevention (CDC) continues our vital work with partners from around the world. CDC maintains strong, collaborative partnerships with country governments including Ministries of Health, as well as non-governmental organizations, leading universities, faith-based organizations, multilateral organizations, and the private sector.
CDC funds partners through Notice of Funding Opportunities (NOFOs) posted each year on Grants.gov. The projects focused on fighting global HIV are part of the US President’s Emergency Plan for AIDS Relief’s work with partners to control the HIV epidemic in each country to achieve a sustainable response.
Frequently Asked Questions
PEPFAR is the U.S. Government initiative to help save the lives of those suffering from HIV around the world. This historic commitment is the largest by any nation to combat a single disease internationally, and PEPFAR investments also help alleviate suffering from other diseases across the global health spectrum. For more information, visit www.pepfar.govExternal.
As America’s leading science-based public health and disease prevention agency, CDC plays a central role in PEPFAR. CDC uses our technical expertise in public health science and long-standing relationships with Ministries of Health across the globe to work side-by-side with countries to build strong national programs and sustainable public health systems. These partners support countries to respond effectively to the global HIV epidemic and to other diseases that threaten the health and prosperity of the global community at large. For more information, visit www.cdc.gov/globalhivtb.
No. CDC has long-standing relationships with Ministries of Health. We work together with Ministries of Health in over 45 countries to lead and manage their national HIV and TB programs by providing direct technical assistance and knowledge transfer. We work with countries to build high-quality laboratory systems and services that are critical for HIV prevention, care and treatment, as well as for other diseases.
The US Government funds HIV programs internationally through PEPFAR. As one of the PEPFAR implementing agencies, CDC funding for global HIV is programmed through the PEPFAR Country Operational Plans and Regional Operational Plans. These plans cover all PEPFAR-funded agencies that are currently operating in foreign countries. For more information, visit www.pepfar.gov/countries/cop/index.htmExternal.
PEPFAR country budgets and activities are submitted through the PEPFAR Country Operational Plans and Regional Operational Plans by the PEPFAR country teams. These plans are then approved by the U.S. Global AIDS Coordinator, and funded by the US Congress. More information on PEPFAR funding can be found at https://data.pepfar.netExternal.
The funding process is a several step process:
Through a thorough analysis of their current portfolio of projects and a consideration of PEPFAR priorities, CDC field offices in country determine if any shifts in programmatic focus or funding are needed, and if there are unmet needs.
Current awards that are due to expire also are reviewed to determine if they include activities that should be continued.
Once the portfolio review is complete and specific projects are agreed and approved, CDC field offices draft a Notice of Funding Opportunity. These undergo a rigorous review by technical and funding subject matter experts.
Once a draft Notice of Funding Opportunity has completed a full review, it is published on www.grants.govExternal. This allows interested organizations to apply for funding. Partners have 60 days to respond from the date a Notice of Funding Opportunity is posted.
Once all applications are received, each application is reviewed and scored against the criteria listed in the Notice of Funding Opportunity. This review process is a merit review, and the particular merit review used is known as “Objective Review Panels”.
The CDC field offices make awards based on the Objective Review Panel results, and applicants are notified.
The overall funding for each project is determined in the PEPFAR Country Operational Plans and Regional Operational Plans through the process described above.
Each award is planned with a funding ceiling, which is the maximum potential funding level. The final funding level is subject to the awardee’s ability to receive and expend funds, as well as the availability of PEPFAR funds.
The overall funding level may change from year to year depending upon the approved work plan and funds made available to CDC by the US Congress.
All grants awarded through CDC follow standard US Government processes. Information on the US Government’s grant management process can be found at www.grants.gov/web/grants/learn-grants.htmlExternal.
Funding opportunities are posted at www.grants.govExternal.
CDC follows US Government regulations regarding grant making. As such, CDC projects are competitively awarded except in select cases where a direct award is deemed appropriate in line with US Government regulations. For more information on the awards criteria and USG regulations regarding grant making, visit www.grants.gov/web/grants/learn-grants/grant-policies.htmlExternal.
Yes. Reflecting PEPFAR’s commitment to country ownership, CDC is a strong supporter of local indigenous organizations. Overall, CDC invests more resources into local, indigenous partners than international partners.
No. For international partners, funding is still spent directly in the partner country, benefiting people living with and affected by HIV and helping to also prevent transmission of the disease in that country. Funds awarded to international organizations also include sub grants to local organizations that also directly support partner countries.
In fiscal year 2018, CDC through the US President’s Emergency Plan for AIDS Relief had a total of 362 cooperative agreements with organizations around the world in support of the ambitious but achievable goal of ending the HIV epidemic by 2030.
Reflecting PEPFAR’s commitment to country ownership, CDC is a strong supporter of local indigenous organizations. Overall, CDC invests more resources into local, indigenous partners than international.
For international partners, funding is still spent directly in the partner country, benefitting people living with and affected by HIV. Funds awarded to international organizations also include sub grants to local organizations that also directly support partner countries.
- Non-Governmental Organization (NGO): A legally constituted organization created by natural or legal persons that operates independently from any government
- Ministry of Health (MOH): Government entity focused on issues related to the general health of the citizens
- Parastatal: A foreign government entity that is not a Ministry of Health
- Multi-Lateral: An organization formed between three or more nations to work on issues that relate to all of the countries in the organization
- Private Entity: Any entity other than a State, local government, Indian tribe, or foreign public entity
CDC Funding Trends for Global HIV over Time
When funding international partners, money is still spent in the country of operation. The awarded funds include sub grants to local organizations and the majority is expended in country.
The overall trend is that CDC invests more resources into local/indigenous partners than international.
Please note all CDC’s Division of Global HIV & TB (DGHT) Notice of Funding Opportunity Announcement (NOFOs) are officially posted and advertised on grants.govExternal which is also used to post Question/Answers and additional information regarding DGHT NOFOs. All formal amendments, changes, and updates to NOFOs can be found at grants.govExternal. It is not possible to submit applications, questions, or seek help with application submissions via this site. For all application submissions and inquiries, please go to grants.govExternal.
Current DGHA FOAs
- 12 18 2015 Caribbean CDC-RFA-GH16-1607Cdc-pdf
- 12 18 2015 Ethiopia CDC-RFA-GH16-1614Cdc-pdf
- 12 18 2015 Malawi CDC-RFA-GH16-1630Cdc-pdf
- 12 18 2015 Namibia CDC-RFA-GH16-1640Cdc-pdf
- 12 18 2015 Zimbabwe CDC-RFA-GH16-1673Cdc-pdf
- 12 19 2015 Haiti CDC-RFA-GH16-1680Cdc-pdf
- 12 19 2015 Kenya CDC-RFA-GH16-1619Cdc-pdf
- 12 19 2015 Kenya CDC-RFA-GH16-1620Cdc-pdf
- 12 19 2015 Kenya CDC-RFA-GH16-1621Cdc-pdf
- 12 19 2015 Kenya CDC-RFA-GH16-1624Cdc-pdf
- 12 19 2015 Kenya CDC-RFA-GH16-1628Cdc-pdf
- 12 19 2015 Kenya CDC-RFA-GH16-1690Cdc-pdf
- 12 19 2015 Kenya CDC-RFA-GH16-1700Cdc-pdf
- 12 19 2015 Kenya CDC-RFA-GH16-1701Cdc-pdf
- 12 19 2015 Kenya CDC-RFA-GH16-1716Cdc-pdf
- 12 19 2015 Kenya CDC-RFA-GH16-1717Cdc-pdf
- 12 19 2015 Malawi CDC-RFA-GH16-1629Cdc-pdf
- 12 19 2015 Nigeria CDC-RFA-GH16-1642Cdc-pdf
- 12 19 2015 Swaziland CDC-RFA-GH16-1646Cdc-pdf
- 12 19 2015 Tanzania CDC-RFA-GH16-1650Cdc-pdf
- 12 19 2015 Zimbabwe CDC-RFA-GH16-1674Cdc-pdf
- 12 22 2015 Tanzania CDC-RFA-GH16-1648Cdc-pdf
- 12 19 2015 Zimbabwe CDC-RFA-GH16-1675Cdc-pdf
- 12 23 2015 Haiti CDC-RFA-GH16-1682Cdc-pdf
- 12 23 2015 Haiti CDC-RFA-GH16-1710Cdc-pdf
- 12 23 2015 Haiti CDC-RFA-GH16-1711Cdc-pdf
- 12 23 2015 Tanzania CDC-RFA-GH16-1652Cdc-pdf
- 12 24 2015 Cote d’Ivoire CDC-RFA-GH16-1612Cdc-pdf
- 12 24 2015 Democratic Republic of Congo CDC-RFA-GH16-1613Cdc-pdf
- 12 24 2015 Haiti CDC-RFA-GH16-1712Cdc-pdf
- 12 24 2015 Tanzania CDC-RFA-GH16-1647Cdc-pdf
- 12 23 2015 Tanzania CDC-RFA-GH16-1653Cdc-pdf
- 12 23 2015 Zambia CDC-RFA-GH16-1668.pdfCdc-pdf
- 12 23 2015 Zambia CDC-RFA-GH16-1669.pdfCdc-pdf
- 12 23 2015 Zambia CDC-RFA-GH16-1670.pdfCdc-pdf
- 12 24 2015 Namibia CDC-RFA-GH16-1639.pdfCdc-pdf
- 12 30 2015 Headquarters CDC-RFA-GH16-1688.pdfCdc-pdf
- 12 30 2015 Mozambique CDC-RFA-GH16-1632.pdfCdc-pdf
- 12 30 2015 Mozambique CDC-RFA-GH16-1634.pdfCdc-pdf
- 12 30 2015 Headquarters CDC-RFA-GH16-1689.pdfCdc-pdf
- 12 30 2015 South Africa CDC-RFA-GH16-1645.pdfCdc-pdf
To view all of the Funding Opportunity Announcement Q&A’s